For our clinical story, we’d like to highlight the incredible work of one of our newer additions to the Pediatric Neuro-Oncology Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Dr. Tabitha Cooney.
Dr. Cooney was recruited in 2019 to serve as the Director of the Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic at the Dana-Farber Cancer Institute. This is a high-volume, multi-disciplinary, and holistic-centered program dedicated to empowering pediatric survivors of brain or spinal cord tumors and their families to lead the healthiest and most fulfilling lives possible. The program has seen tremendous growth under her leadership, with an emphasis on the importance of evidence-based clinical care, education and research, and providing the best care for these patients. Even amidst a COVID pandemic, she championed a multi-disciplinary approach to care for our brain and spinal cord tumor survivors. In fact, the program is currently conducting a survey to evaluate the effectiveness of a multi-disciplinary tele-health experience. Dr. Cooney is also currently leading institutional and national retrospective projects through the Childhood Cancer Survivor Study to better understand the multi-faceted and overlapping health challenges that our pediatric brain tumor survivors face.
Dr. Cooney’s research programs and collaborations aim to improve survival in pediatric brain and spinal cord tumors through novel therapeutic and design interventions, as well as improve overall health outcomes for pediatric brain and spinal cord tumor survivors. She initiated and co-leads multi-institutional therapeutic trials across pediatric oncology consortia including the Children’s Oncology Group (COG), Pediatric Brain Tumor Consortium (PBTC), and Pediatric Neuro-Oncology Consortium (PNOC). She also serves in leadership positions on international organizations like PNOC and the Pediatric Low-Grade Astrocytoma Coalition, where she is working on collaborative initiatives to characterize long-term outcomes of new chronic oral therapies and immunotherapies.
We are proud to have Dr. Cooney as one of our colleagues and champions in the care of brain and spinal cord tumor patients and survivors!